Anders Månsson

Anders Månsson Email and Phone Number

Senior Advisor and Advisory Board Member @ Ventures Accelerated Life Science
Malmö, SE
Anders Månsson's Location
Greater Malmö Metropolitan Area, Sweden
Anders Månsson's Contact Details

Anders Månsson personal email

About Anders Månsson

Anders Månsson is a Senior Advisor and Advisory Board Member at Ventures Accelerated Life Science. He possess expertise in pharmaceutical industry, market access, global marketing, pharmaceutical sales, product launch and 21 more skills. He is proficient in German and Danish.

Anders Månsson's Current Company Details
Ventures Accelerated Life Science

Ventures Accelerated Life Science

View
Senior Advisor and Advisory Board Member
Malmö, SE
Website:
venturesaccelerated.com
Employees:
12
Anders Månsson Work Experience Details
  • Ventures Accelerated Life Science
    Senior Advisor And Advisory Board Member
    Ventures Accelerated Life Science
    Malmö, Se
    View
  • Phase Holographic Imaging
    Chief Executive Officer
    Phase Holographic Imaging Nov 2024 - Present
    Lund, Skåne County, Sweden
    PHI (Phase Holographic Imaging) is a development company in digital microscopy/cytometry. The company’s HoloMonitor® live cell imaging system supports the development of cell therapy by allowing individual cells to be non-invasively visualized with holography and quantified over time on a population level inside a cell incubator. The system relies on AI for digital image interpretation enhancement. The existing product versions are already well established in academia, they are used across the world, and their performance is backed by plentiful scientific publications. And upgraded versions are in development.
    View
  • Immetric
    Partner & Member Of The Board
    Immetric Jan 2022 - Present
    Malmö, Skåne County, Sweden
    Immetric is a Europe focused seed capital investment fund that can add top notch IP verification and advice, as well as start-up savviness, on top of the investment capital that it provides for early stage innovation in tech and life sciences.
    View
  • Eql Pharma Ab (Publ)
    Member Of The Board (Chairman 2020-2022)
    Eql Pharma Ab (Publ) Aug 2018 - Present
    Lund, Sweden
    EQL Pharma is a listed niche generics- and speciality pharma company, dedicated to providing cost effective pharmaceuticals for the European markets.
    View
  • Oncoinvent As
    Chief Executive Officer
    Oncoinvent As Aug 2023 - Nov 2024
    Oslo, Norway
    Based in Oslo, Norway, Oncoinvent has some 50 employees. It is privately held and backed by VC. The company has thus far demonstrated excellent clinical results with its key radio-pharmaceutical product candidate, Radspherin®, for Peritoneal Carcinomatosis (PC). The goal is to continue this development journey, and ultimately establish a new standard therapy in the area.
    View
  • Lidds
    Chief Executive Officer
    Lidds Sep 2022 - Aug 2023
    Sweden
    LIDDS is a technology platform company specialising in depot formulations for intra-tumoral injections with its NanoZolid technology. This allows for effective dose delivery while minimising systemic side effects, an important feature in oncology. LIDDS focuses on early-stage partnership with pharmaceutical companies, for new and established APIs, and LIDDS also does proprietary drug development for out-licensing in pre-clinical or clinical phase.
    View
  • Rhovac (Later Merged With Chosa)
    Chief Executive Officer
    Rhovac (Later Merged With Chosa) Sep 2019 - Aug 2022
    Lund, Sweden
    RhoVac AB was a Swedish publicly listed bio-pharmaceutical company dedicated to drug development in the oncology area. RhoVac merged with Chosa in 2022.
  • Amniotics Ab
    Member Of The Board
    Amniotics Ab May 2016 - Aug 2022
    Lund, Sweden
    Amniotics AB is a stem cell research based company backed by, among others, venture capitalist and renowned serial entrepreneur Christer Fåhraeus. The mission of the company is to produce, with amniotic fluid as the source, cutting edge stem cell therapy for the benefit of patients around the world.
    View
  • Amniotics Ab
    Ceo
    Amniotics Ab Jun 2017 - May 2019
    Lund, Sweden
    My main role as CEO was first and foremost to turn the company’s discoveries, inventions and patents into value generating and workable business models. As CEO, I took the company to its first external funding round.
    View
  • Rhovac
    Chief Business Officer & Deputy Ceo
    Rhovac May 2019 - Sep 2019
    Lund, Sweden
    View
  • Canimguide Therapeutics Ab
    Chairman Of The Board
    Canimguide Therapeutics Ab Jun 2017 - Jun 2019
    Malmo, Sweden
    CanImGuide Therapeutics AB was founded in 2006 in order to further develop new treatments, primarily for cancer, by targeting peptide sequences related to immunosuppression. I left the CIG Board when I joined RhoVac on the basis of "non-compete".
  • Ratos
    Industrial Advisor
    Ratos Sep 2016 - May 2019
    Stockholm, Sweden
    Ratos AB is a listed Swedish Private Equity Company with a Market Cap in excess of 1 Billion USD, and I acted as an Industrial Advisor for them in the area of Life Sciences.
    View
  • Respiratorius Ab
    Member Of The Board
    Respiratorius Ab May 2016 - May 2019
    Lund, Sweden
    Respiratorius AB is company that develops new and effective candidate drugs for treatment of cancer, COPD and asthma. Respiratorius (RESP) is listed at the Equities Market Place ("Spotlight Stock Market") since 2012. I left the Respiratorius Board when I joined RhoVac on the basis of "non-compete".
    View
  • Leo Pharma
    Vice President, Global Commercial Portfiolio Management
    Leo Pharma Dec 2016 - May 2017
    Copenhagen Area, Denmark
    Heading global brand management, commercial insights, market access, pricing and scientific affairs (the latter through dotted line) for the Group’s portfolios in Psoriasis, Skin Cancer and OTC/Consumer. These portfolios are the mainstay of LEO and the annual turnover of the strategic brands in these categories is ca. ½ Billion EUR. My team of ca. 30 heads lead the strategic development of these portfolios and it operated in matrix with the Regional M&S operations (US, EU+ and International) as well as with R&D and other corporate functions.
    View
  • Leo Pharma
    Vice President, Head Of Global Business Development
    Leo Pharma Oct 2014 - Nov 2016
    Copenhagen Area, Denmark
    Heading the Global Business Development function (Acquisition Strategy, Partnerships and M&A execution) for the LEO Group. In essence responsible for leading the development and implementation of strategies for inorganic growth, including transaction execution. Member of the LEO Global Management Team (GMT). In my time at the helm of Global Business Development, LEO made two record breaking transactions: 1. The acquisition of the global dermatology portfolio from Astellas (Upfront payment 675 Million EUR). 2. A Strategic Alliance & in-licence deal with Astra-Zeneca on biologics in the field of dermatology (Upfront payment 125 Million EUR + milestone payments potentially reaching in excess of a Billion EUR). See the Projects headline below for more information.
    View
  • Leo Pharma
    Vice President, Global Business Unit Head
    Leo Pharma May 2011 - Sep 2014
    Copenhagen, Denmark
    Global P&L responsibility, and cross functional leadership (sales, marketing, finance, regulatory & supply), for LEO Pharma's corporate established products division. Turnover ca. 150 Million EUR. Ca. 70 solid line reports. Member of the Global Sales & Marketing Management Team as well as of the cross functional LEO Top Leadership Team (LTLT). The unit made a slew of out-licenisng deals and also one major global divestment, for which I was operationally in charge: The global divestment of Fucithalmic (antibiotic for eye infection) for an upfront payment of 84 Million EUR + CMO contract. See the Projects headline below for more information.
    View
  • Ferring Pharmaceuticals
    General Manager
    Ferring Pharmaceuticals Jun 2007 - Apr 2011
    Copenhagen, Denmark
    General Manager with full P&L responsibility, and cross functional leadership (sales, marketing, finance, regulatory & medical), for Ferring's Danish S&M Affiliate. Turnover ca. 15 Million EUR.
    View
  • Ferring Pharmaceuticals
    Senior Director, Global Marketing & Business Development
    Ferring Pharmaceuticals Jul 2005 - Jun 2007
    St Prex, Vd, Switzerland
    Re-building in the new HQ in Switzerland, and heading a corporate function with an integrated responsibility for Corporate Strategic Planning, Business Intelligence, Pricing & Market Access. The unit did BD acquisition target evaluation, R&D pipeline evaluation as well as managing business analytics, pricing and intelligence at the corporate level.
    View
  • Ferring Pharmaceuticals
    Director, Global Marketing & Business Development
    Ferring Pharmaceuticals May 2003 - Jun 2005
    Copenhagen, Denmark
    Starting and heading a corporate function with an integrated responsibility for Corporate Strategic Planning, Business Intelligence, Pricing & Market Access. The unit did BD acquisition target evaluation, R&D pipeline evaluation as well as managing business analytics, pricing and intelligence at the corporate level.
    View
  • Ferring Pharmaceuticals
    Associate Director, Eu/Global Sales & Operations Planning
    Ferring Pharmaceuticals May 2000 - Apr 2003
    Copenhagen, Denmark / London, Uk
    Planning and executing business affiliate reviews/audits, first with a European scope, then with a global one. Project management spanning S&M and Supply Chain functions.
    View
  • Ferring Läkemedel Ab
    Business Unit Manager, Ob/Gyn & Head Of Key Account Management
    Ferring Läkemedel Ab Apr 1998 - Apr 2000
    Malmö, Sweden
    Starting & heading a national Ob/Gyn Business Unit and also heading national Key Account & Tender Management across therapy areas
    View
  • Ferring Läkemedel Ab
    Product Manager
    Ferring Läkemedel Ab Jan 1995 - Mar 1998
    Malmö, Sweden
    Product Management, Urology, first on a national (Swedish) basis, then on a regional (Nordic) basis
    View
  • Ferring Läkemedel Ab
    Product Specialist
    Ferring Läkemedel Ab Aug 1993 - Dec 1994
    Malmö, Sweden
    Managing District Sales, Urology
  • Meda Pharma
    Sales Rep
    Meda Pharma Aug 1992 - Jul 1993
    Malmö, Sweden
    Managing District Sales, Rx
    View

Anders Månsson Skills

Pharmaceutical Industry Market Access Global Marketing Pharmaceutical Sales Product Launch Sales Effectiveness Pharmaceutics Life Sciences Marketing Management Oncology Biotechnology Clinical Trials Urology Hospital Sales Clinical Development Regulatory Affairs Gastroenterology Lifesciences Health Economics Dermatology Medical Devices Strategy Business Development Cross Functional Team Leadership General Management Commercial Management

Frequently Asked Questions about Anders Månsson

What company does Anders Månsson work for?

Anders Månsson works for Ventures Accelerated Life Science

What is Anders Månsson's role at the current company?

Anders Månsson's current role is Senior Advisor and Advisory Board Member.

What is Anders Månsson's email address?

Anders Månsson's email address is an****@****ail.com

What skills is Anders Månsson known for?

Anders Månsson has skills like Pharmaceutical Industry, Market Access, Global Marketing, Pharmaceutical Sales, Product Launch, Sales Effectiveness, Pharmaceutics, Life Sciences, Marketing Management, Oncology, Biotechnology, Clinical Trials.

Not the Anders Månsson you were looking for?

View similar profiles

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.